Nasdaq
GLMD
Galmed Pharmaceuticals Ltd.
- Health Care
- Israel
- Listed 2014
- 1 day
- +3.3%
- 1 month
- +5.3%
- 1 year
- −58.7%
$0.5990 · Mkt cap $4.60M · P/E 0.25
At the 6 Aug 2026 close
Nasdaq
Galmed Pharmaceuticals Ltd.
$0.5990 · Mkt cap $4.60M · P/E 0.25
At the 6 Aug 2026 close
Galmed Pharmaceuticals Ltd. trades under the ticker GLMD on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2014. Its market capitalisation is $4.60M. The last closing price was $0.5990, on 6 Aug 2026. It trades at 0.25 times its last reported annual diluted earnings per share. Over the past year the share price is −58.7%, and +5.3% over the past month. Returns are price returns and exclude dividends.
This page exists because GLMD is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.